Clinical Trials | December 13, 2023
Progenesis opens genetic laboratory in New Delhi and AI & Bioinformatics data centre in Chennai
Leading USA based genetic testing brand officially enters the Indian market
Leading USA based genetic testing brand officially enters the Indian market
Submissions based on positive data from the Phase 3 BASIS trial, which were presented this past weekend at the American Society of Hematology (ASH) Annual Meeting
The CVMP recommends the product for approval for the treatment and persistent killing of fleas
The exclusive agreement also includes development, regulatory, and commercialization milestone payments based on the successful outcome
New facility is part of Aptar Pharma’s global expansion program
Conditional marketing authorization is based on clinically meaningful response rates, duration of response, and safety from the Phase 2 MagnetisMM-3 trial
This acquisition marks Max Healthcare's entry into Lucknow
Express Scripts to add Zepbound to National Preferred Formulary
his marks the 12th formulation facility under Akums, and the second in Baddi, a strategic move with an aim to enhance Akums’ manufacturing capabilities.
Methylene blue is a cationic thiazine dye that necessitates specialised capabilities and expertise to develop and manufacture the product
Subscribe To Our Newsletter & Stay Updated
